rs2107732

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031443.4(CCM2):​c.157G>A​(p.Val53Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0791 in 1,614,010 control chromosomes in the GnomAD database, including 5,764 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V53V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.060 ( 386 hom., cov: 32)
Exomes 𝑓: 0.081 ( 5378 hom. )

Consequence

CCM2
NM_031443.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.09

Publications

30 publications found
Variant links:
Genes affected
CCM2 (HGNC:21708): (CCM2 scaffold protein) This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]
CCM2 Gene-Disease associations (from GenCC):
  • cerebral cavernous malformation 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • famililal cerebral cavernous malformations
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013820231).
BP6
Variant 7-45038379-G-A is Benign according to our data. Variant chr7-45038379-G-A is described in ClinVar as Benign. ClinVar VariationId is 261965.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0919 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCM2NM_031443.4 linkc.157G>A p.Val53Ile missense_variant Exon 2 of 10 ENST00000258781.11 NP_113631.1 Q9BSQ5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCM2ENST00000258781.11 linkc.157G>A p.Val53Ile missense_variant Exon 2 of 10 1 NM_031443.4 ENSP00000258781.7 Q9BSQ5-1

Frequencies

GnomAD3 genomes
AF:
0.0604
AC:
9192
AN:
152116
Hom.:
386
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0158
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.0544
Gnomad ASJ
AF:
0.0988
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0307
Gnomad FIN
AF:
0.0598
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0937
Gnomad OTH
AF:
0.0712
GnomAD2 exomes
AF:
0.0631
AC:
15863
AN:
251384
AF XY:
0.0635
show subpopulations
Gnomad AFR exome
AF:
0.0139
Gnomad AMR exome
AF:
0.0375
Gnomad ASJ exome
AF:
0.108
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0681
Gnomad NFE exome
AF:
0.0901
Gnomad OTH exome
AF:
0.0777
GnomAD4 exome
AF:
0.0811
AC:
118554
AN:
1461776
Hom.:
5378
Cov.:
33
AF XY:
0.0804
AC XY:
58488
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0119
AC:
398
AN:
33480
American (AMR)
AF:
0.0393
AC:
1756
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
2713
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0344
AC:
2970
AN:
86258
European-Finnish (FIN)
AF:
0.0717
AC:
3830
AN:
53380
Middle Eastern (MID)
AF:
0.0563
AC:
325
AN:
5768
European-Non Finnish (NFE)
AF:
0.0915
AC:
101734
AN:
1111940
Other (OTH)
AF:
0.0799
AC:
4823
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
6020
12040
18061
24081
30101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3612
7224
10836
14448
18060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0604
AC:
9189
AN:
152234
Hom.:
386
Cov.:
32
AF XY:
0.0569
AC XY:
4236
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0157
AC:
654
AN:
41546
American (AMR)
AF:
0.0544
AC:
831
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0988
AC:
343
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.0303
AC:
146
AN:
4822
European-Finnish (FIN)
AF:
0.0598
AC:
634
AN:
10600
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0938
AC:
6377
AN:
68004
Other (OTH)
AF:
0.0700
AC:
148
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
428
857
1285
1714
2142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0802
Hom.:
1480
Bravo
AF:
0.0589
TwinsUK
AF:
0.0936
AC:
347
ALSPAC
AF:
0.0944
AC:
364
ESP6500AA
AF:
0.0170
AC:
75
ESP6500EA
AF:
0.0897
AC:
771
ExAC
AF:
0.0628
AC:
7628
Asia WGS
AF:
0.0200
AC:
69
AN:
3478
EpiCase
AF:
0.0887
EpiControl
AF:
0.0829

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cerebral cavernous malformation 2 Benign:4
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 12, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 09, 2018
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
19
DANN
Benign
0.84
DEOGEN2
Benign
0.041
T;.;T;.;T
Eigen
Benign
0.047
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.81
T;T;T;T;T
MetaRNN
Benign
0.0014
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.14
N;N;.;.;.
PhyloP100
7.1
PrimateAI
Uncertain
0.48
T
PROVEAN
Benign
0.23
N;N;N;N;N
REVEL
Benign
0.11
Sift
Benign
0.87
T;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T
Polyphen
0.18
B;.;.;.;.
Vest4
0.054
MPC
0.29
ClinPred
0.047
T
GERP RS
5.4
Varity_R
0.053
gMVP
0.12
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2107732; hg19: chr7-45077978; COSMIC: COSV104578961; API